About
Technology
Issues
FAQ
Links
Official Page
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.